Key result
Glycated albumin offers a promising alternative to HbA1c for faster glycaemic monitoring in specific populations.
Why the study?
Does glycated albumin monitoring improve glycaemic control assessment compared to HbA1c in diabetic patients?
Does glycated albumin monitoring improve glycaemic control assessment compared to HbA1c in diabetic patients?
Glycated albumin may serve as a more accurate and rapidly responsive alternative to HbA1c for monitoring glycaemic control, particularly in patients with conditions that alter HbA1c concentrations.
Answers are grounded in this paper and cite their sources.
May warrant consideration where HbA1c is unreliable; leaves open need for prospective trials before routine adoption.
A rise in concentrations of glycated proteins occurs in diabetic patients; glycated hemoglobin is the most significant parameter, a ‘gold standard’ for glycaemic control. Other serum proteins also become glycated, i.a albumins and immunoglobulins. In practice, Fructosamine and glycated albumin are used. However, some conditions influence HbA1c concentrations, hence the search for alternative biomarkers for glycaemia monitoring. Glycated albumin (GA) appears to be the most promising, as its assessment enables both faster detection of changes in glycaemia control in cases of poor metabolic discipline and documentation of glyceamic control improvement, after appropriate treatment is implemented. This may be important mostly in patients scheduled for surgical, cardiosurgical or orthopedic procedures, which are sometimes postponed because of inadequate glycaemia control. Monitoring GA in particular groups of patients (i.a during pregnancy, with renal insufficiency or haematologic comorbidities) reflects glycaemic control levels more accurately than HbA 1c .
No takes yet. Share an insight, caveat, or question.
Cichocka et al. (2017) conducted a review in Diabetes. Alternative biomarkers (Glycated albumin, Fructosamine) vs. HbA1c was evaluated. Glycated albumin serves as a promising alternative to HbA1c for glycaemic monitoring, offering faster detection of metabolic changes and greater accuracy in specific patient populations.
Synapse has enriched 10 related papers. Consider them for comparative context: